Career
He co-invented blue light acne vulgaris phototherapy, as well as a radio frequency device for home treatment for wrinkle reduction. Yoram Harth"s father was a physician who specialised in internal medicine. Harth is a Magna cum Laude graduate of the Sackler School of Medicine in Tel Aviv University (1982).
He co-founded the Phototherapy Unit, Rambam Medical center, and was Director of the Photodynamic Therapy Unit, Elisha Medical Center in Haifa.
Harth served on the faculty of American Academy of Dermatology (AAD) as part of the Photobiology training team and the American Society for Laser Medicine and Surgery (ASLMS). Harth holds several patents and has authored a number of papers and book chapters.
Starting in 1998 Harth co-founded Curelight, an Israeli company, and developed Clearlight, an acne phototherapy therapy system. Curelight was chosen by the Israeli Venture Capital Association as Best Startup company of 2002 (Medical Devices).
Curelight was a finalist in the contest Entrepreneur of the year 2003, (Ernst & Young, Israel).
Harth was also a pioneer in the development of other novel devices for dermatological treatment among them the patented invention in the field of targeted multi–wavelength phototherapy for psoriasis and Vitiligo. In 2007 Harth co-founded Endymed Medical and Israeli company specializing in multisource radiofrequency devices for the professional and home use markets. This technology allows multiple aesthetic treatments including painless skin tightening and lifting for the face and body.
Fraction of a RF skin resurfacing for skin rejuvenation, acne scars and stretch and more.
Endymed’s home use device was the world’s first energy based RF device to be approved by the Food and Drug Administration for home use facial wrinkle reduction. Endymed medical was the Europe fastest growing biomedical company in the Deloitte Touche fast 500 list for 2013 and is traded on the Tel Aviv Stock Exchange (ENDY:TASE).